Treatment with interferon in early COVID-19
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
COVID-19: investigational drugs
Famotidine associated with improved clinical outcomes in people hospitalised with COVID-19
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Tocilizumab and remdesivir in new dual therapy study
1 June 2020. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
RETRACTED – Re: No benefit from hydroxychloroquine, with or without macrolide antibiotics in analysis of 96,000 participants
1 June 2020. Related: COVID-19: investigational drugs, COVID-19.
Remdesivir for COVID-19: randomised study shows similar antiviral effect to placebo
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Other remdesivir news: top results from NIH and Gilead studies – emergency approval in US and Japan
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Potential for tocilizumab to treat moderate to severe COVID-19
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Detectable viral load and IL-6: a role for tocilizumab or anti-JAK inhibitor baricitinib?
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Rheumatoid arthritis drug anakinra in small study to treat COVID-19
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Anticoagulants associated with improved survival rates in people hospitalised with COVID-19
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Monoclonal antibodies identified in convalescent plasma COVID-19
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Studies reporting lack of benefit from hydroxychloroquine to treat COVID-19
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Israeli cohort shows no protection against COVID-19 from childhood BCG vaccination
14 May 2020. Related: COVID-19: investigational drugs, COVID-19.
Remdesivir for COVID-19: first results from compassionate access programme
17 April 2020. Related: COVID-19: investigational drugs, COVID-19.
No benefit of hydroxychloroquine and azithromycin in people hospitalised with COVID-19
17 April 2020. Related: COVID-19: investigational drugs, COVID-19.
High-dose chloroquine study for COVID-19 stopped with worse outcomes: high risk of cardiovascular events
17 April 2020. Related: COVID-19: investigational drugs, COVID-19.
Gilead expand UK sites for two phase-3 studies of remdesivir to treat COVID-19
17 April 2020. Related: COVID-19: investigational drugs, COVID-19: research studies, COVID-19.
Early drugs being studied for COVID-19
27 March 2020. Related: Treatment strategies, COVID-19: investigational drugs, COVID-19.